✦ For everyone, free.

Practical knowledge for real and everyday life

Home

1.1.14 Cancer Cell Lineage Definition

What a cancer cell lineage is, including how ancestral relationships between tumor cells are traced over time.

Cancer Cell Lineage Definition is the description of the developmental and evolutionary trajectory that connects a cancer cell to its cell of origin and traces the successive generations of division and diversification that produced the tumor as it exists at any given point in time. Where a clone captures a group of cells sharing a common ancestor, lineage captures the fuller genealogical record, the ordered sequence of ancestor-to-descendant relationships that explains not just which cells are related but how and when their relationships branched.


Cell of Origin

Identifying the Starting Point

Every cancer lineage begins with a specific normal cell type that undergoes the initial transforming events. Identifying this cell of origin, whether it is an epithelial cell, a blood-forming precursor, or a connective tissue cell, helps explain many of the tumor's baseline characteristics, since descendant cancer cells often retain some molecular features of the tissue from which they arose.

Distinguishing Origin from Histological Classification

The cell of origin is not always identical to the cell type suggested by the tumor's final appearance, since malignant transformation and subsequent dedifferentiation can cause a cancer to look quite different from the normal cell that first gave rise to it.


Tracing Lineage Through Division

Vertical Transmission of Mutations

As a lineage progresses through successive rounds of division, each new generation of cells inherits the mutations present in its parent cell and may acquire additional mutations of its own. This vertical inheritance pattern allows researchers to reconstruct a family tree of the tumor based on which mutations are shared and which are unique to particular branches.

Lineage Trees and Phylogenetics

Techniques borrowed from evolutionary biology can be applied to cancer, treating each subclone as a branch on a phylogenetic tree rooted at the original founder cell. These lineage trees visually and mathematically represent the order in which mutational events occurred and how different regions of a tumor relate to one another.


Lineage Plasticity

Departure from the Original Cell Identity

In some cancers, cells within a lineage can undergo lineage plasticity, shifting away from the molecular identity of their cell of origin and adopting characteristics more typical of a different, often less differentiated, cell type. This capacity for lineage switching can occur spontaneously or in response to the selective pressure of therapy.

Consequences of Lineage Switching

When cells within a lineage switch identity, the resulting tumor cells may no longer respond to therapies that were effective against the original lineage, since the molecular targets and vulnerabilities associated with the earlier identity may no longer be present.


Lineage and Metastasis

Seeding of Distant Lineages

When cells disseminate from a primary tumor and establish a metastatic growth at a distant site, that new growth represents a distinct branch of the same overall lineage, having descended from a particular subclone within the primary tumor at a particular point in time.

Reconstructing the Path of Spread

By comparing the mutational profiles of primary and metastatic lesions, it is possible to reconstruct which lineage branch gave rise to the metastasis and approximately when the seeding event occurred relative to the tumor's overall evolutionary history.


Clinical and Research Significance

Lineage analysis provides a framework for understanding how a tumor has evolved over time, which cellular ancestry underlies its current behavior, and how metastatic lesions relate to the primary tumor from which they arose. This information supports more precise diagnosis, helps explain patterns of drug resistance, and informs strategies aimed at targeting the earliest, most broadly shared vulnerabilities within a tumor's lineage.